SAM
FLNA

Smartleaf Asset Management’s Filana Therapeutics FLNA Stock Holding History

Smartleaf Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22K Hold
1,369
– – ﹤0.01% 2936
2025
Q4 		$2.78K Buy
+1,369
New +$4.38K ﹤0.01% 2883

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Smartleaf Asset Management's FLNA Position: Q1 2026 in Review

Smartleaf Asset Management held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 1,369 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2936.

Smartleaf Asset Management first reported a position in FLNA in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.78K in Q4 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Smartleaf Asset Management held 1,369 shares of Filana Therapeutics worth $2.22K as of Q1 2026.
  • Smartleaf Asset Management left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2936 holding.
  • Smartleaf Asset Management first reported a position in Filana Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Smartleaf Asset Management's Filana Therapeutics position peaked at $2.78K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.